NASDAQ · Medical - Instruments & Supplies

Pulse Biosciences, Inc (PLSE) Stock

$53.81 +7.66% NASDAQ: PLSE Healthcare

Valuation

MetricValue
Price$53.81
Market Cap$3.72B
P/E Ratio-43.16
P/B Ratio35.12
P/S Ratio2949.44
EPS (TTM)$-0.88
52-Week High$58.90
52-Week Low$12.56
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-94.42%
ROA-69.27%
ROCE-79.40%
Gross Margin-91.08%
Operating Margin-103.92%
Net Margin-99.29%
Debt/Equity0.07
Current Ratio10.38

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$1.0M$0$0$0
Operating Profit$-63.0M$-58.0M$-44.0M$-56.0M$-77.0M
Net Profit$-64.0M$-59.0M$-42.0M$-54.0M$-73.0M
EPS$-2.28$-1.72$-0.88$-0.92$-1.08
Op Margin-4443.9%-8293.9%——-21982.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$54.0M$78.0M$59.0M$132.0M$96.0M
Total Liabilities$19.0M$80.0M$15.0M$18.0M$15.0M
Cash$29.0M$61.0M$44.0M$118.0M$81.0M
Borrowings$11.0M$76.0M$9.0M$9.0M$8.0M

Latest News

Pulse Biosciences Schedules Second Quarter 2026 Financial Results Conference Call for August 6, 2026 Business Wire · Jul 21, 2026 Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire · Jul 15, 2026 Sector Update: Healthcare Stocks Mixed Premarket Wednesday MT Newswires · Jun 10, 2026 Pulse Biosciences to Redeem Remaining Warrants From July 2024 Offering MT Newswires · Jun 10, 2026 Pulse Biosciences, Inc. Announces Planned Redemption of Warrants Business Wire · Jun 10, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-54.0M$-47.0M$-33.0M$-36.0M$-54.0M
Investing Cash Flow$7.0M$-1.0M$0$0$-1.0M
Financing Cash Flow$63.0M$0$0$50.0M$0
Net Cash Flow$16.0M$33.0M$-17.0M$74.0M$-37.0M
Free Cash Flow$-55.0M$-47.0M$-33.0M$-36.0M$-54.0M

Valuation & Return Ratios

MetricValue
PEG Ratio4.36
EV / EBITDA-42.58
FCF Yield-1.76%
Quick Ratio9.61
Interest Coverage0.00
Return 1Y116.09%
Return 3Y392.63%
Return 5Y63.31%

Ownership

Insiders Held73.21%
Institutions Held12.30%
Institutions Float Held45.90%
Institutional HolderSharesReport Date
Blackrock Inc.1,339,7782026-03-31
Bank of America Corporation866,0612026-03-31
Vanguard Capital Management LLC815,8522026-03-31
Portolan Capital Management, LLC733,3722026-03-31
Geode Capital Management, LLC491,9462026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.68 -1.10% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About Pulse Biosciences, Inc

Pulse Biosciences, Inc (PLSE) stock trades at $53.81 with a market capitalization of $3.72B. The stock is valued at a price-to-earnings (P/E) ratio of -43.16, price-to-book of 35.12, price-to-sales of 2949.44. Over the past 52 weeks the stock has ranged between $12.56 and $58.90, and currently trades 8.6% below its 52-week high.

On profitability, Pulse Biosciences, Inc generates a return on equity (ROE) of -94.42%, return on capital employed of -79.40%, an operating margin of -103.92%, a net profit margin of -99.29%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.31 +0.33% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.67 +1.27%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides